1-Hydroxybenzotriazole → HCID 57920110, compound
Reaction equation
[CH2:1]([O:8]C1C=CC=CC=1OC1CN([C@@H](CC2CCCCC2)C(O)=O)C(=O)C=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.Cl.CN(C)[CH2:36][CH2:37][CH2:38]N=C=NCC.[CH:45](N(CC)C(C)C)(C)C.ON1C2C=CC=CC=2N=N1.Cl.[OH:65][C@@H:66]([CH2:96]O)[CH2:67][N:68]1[CH:72]=[CH:71][C:70]([NH:73][C:74](=[O:95])[C@@H:75]([N:80]2[CH2:84][C:83]([O:85][C:86]3[CH:91]=[CH:90][CH:89]=[C:88](Cl)[C:87]=3Cl)=[CH:82][C:81]2=[O:94])[CH2:76][CH:77]([CH3:79])[CH3:78])=[N:69]1>ClCCl.C(OCC)(=O)C>[CH2:1]([O:8][C:87]1[CH:88]=[CH:89][CH:90]=[CH:91][C:86]=1[O:85][C:83]1[CH2:84][N:80]([C@@H:75]([CH2:76][CH:77]2[CH2:78][CH2:38][CH2:37][CH2:36][CH2:79]2)[C:74]([NH:73][C:70]2[CH:71]=[CH:72][N:68]([CH2:67][C:66]([OH:65])([CH3:45])[CH3:96])[N:69]=2)=[O:95])[C:81](=[O:94])[CH:82]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 23 °C
Procedure
To a stirred solution of (S)-2-[4-(2-benzyloxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-3-cyclohexyl-propionic acid (150 mg, 0.3 mmol) in dichloromethane (10 mL) was gradually added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (197 mg, 1.0 mmol) and N,N-diisopropylethylamine (220 mg, 1.7 mmol) at room temperature, under nitrogen. After 15 min, 1-hydroxybenzotriazole (158 mg, 1.0 mmol) and 1-(3-amino-pyrazol-1-yl)-2-methyl-propan-2-ol (prepared in U.S. Pat. Appl. US2008021032 Example 80, 54 mg, 0.3 mmol) were added to the reaction mixture. The reaction mixture was then stirred at 23° C. for 48 h. The reaction mixture was diluted with ethyl acetate and washed with a saturated aqueous ammonium chloride solution followed by a saturated aqueous sodium bicarbonate solution. The organic layer was then washed with a saturated aqueous sodium chloride solution, separated, dried over sodium sulfate and concentrated in vacuo to afford the crude product, which was purified by flash column chromatography (silica gel (100-200 mesh)) which afforded (S)-2-[4-(2-benzyloxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-3-cyclohexyl-N-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-propionamide (58 mg, 29%) as an off-white solid: 1H NMR (400 MHz, DMSO-d6) δ ppm 0.79-0.97 (m, 2H), 1.05 (s, 3H), 1.06 (s, 3H), 1.08-1.31 (m, 4H), 1.53-1.82 (m, 7H), 3.90 (s, 2H), 4.10 (d, J=18.1 Hz, 1H), 4.56 (d, J=18.1 Hz, 1H), 4.66 (s, 1H), 4.73 (s, 1H), 4.91 (dd, J=10.5, 4.6 Hz, 1H), 5.17 (s, 2H), 6.45 (d, J=2.0 Hz, 1H), 6.99-7.07 (m, 1H), 7.21-7.41 (m, 8H), 7.54 (d, J=2.0 Hz, 1H), 10.75 (s, 1H).
Workup
- customat room temperature
- washwashed with a saturated aqueous ammonium chloride solution
- washThe organic layer was then washed with a saturated aqueous sodium chloride solution
- customseparated
- dry with materialdried over sodium sulfate
- concentrationconcentrated in vacuo
- customto afford the crude product, which
- customwas purified by flash column chromatography (silica gel (100-200 mesh)) which
Sources & evidence
- ORD record
- ord-424b6858a79246fa8110f2e5697fa6ee
- Source dataset
- uspto-grants-2010_06
- Patent number
- US07741327B2
Reaction notes
Loading…